Indefinite Delivery Contract 36C25526D0052
- Not listed
- The Department of Veterans Affairs Veterans Integrated Service Network 10 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on May 1, 2026, for hazardous pharmaceutical compounding services, with a ceiling of $7,570,831.40 and an ultimate completion date of April 30, 2027. This is a single-award, no-set-aside contract. Optum Infusion Services 308, LLC will perform work at multiple VA Medical Centers across Indiana, Ohio, and Michigan, with administrative oversight at...
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, holds a single-award Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs Veterans Integrated Service Network 2 (VISN 2) for the provision of chemotherapy compound chemical mixes. The agreement, valued at $500,000, was awarded on August 24, 2021, with an ultimate completion date of August 23, 2026. The contract employs a firm fixed-price pricing structure with no set-aside designation,...
- Veterans Integrated Service Network 2 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on August 24, 2026, with a ceiling of $240,583.99 for compounded chemotherapy drugs, in a single-award procurement with no set-aside designation. Place of performance is Chandler, Arizona. The contract stems from a sole-source solicitation (36C24226Q0550) issued April 20, 2026, to procure ready-to-administer, patient-specific chemotherapy drugs prepared under FDA 503A compliance, VHA...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
- Veterans Integrated Service Network 16 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on May 7, 2026, for contingency medication compounding services under Executive Order 14398, with a contract ceiling of $2.5 million and ultimate completion date of May 6, 2031. This is a single-award, no-set-aside contract. Place of performance is Houston, Texas (Michael E. DeBakey VA Medical Center, Building 100, Room 2A-290, 2002 Holcombe Boulevard, Houston, Texas 77030). The...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a single-award indefinite-delivery contract to Optum Infusion Services 308, LLC on October 1, 2024, with a ceiling of $6,753,050 and performance through September 30, 2029. The contract covers pharmacy hazardous compounding services under Executive Order 14398. Work is performed at multiple locations including Biloxi, Mississippi and Pensacola, Florida, with operations supported from additional VA...
- Optum Pharmacy 801, Inc., a 503A certified specialty pharmacy subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Blanket Purchase Agreement valued at $2,623,503.94 by Veterans Integrated Service Network 2 (VISN 2) on November 17, 2021, for chemotherapy compounding services. The contract was awarded through full and open competition without set-aside designation and extends through November 16, 2026. As the prime contractor, Optum Pharmacy 801 operates from its Phoenix...
- Veterans Integrated Service Network 16 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on October 15, 2025, for 503A pharmaceutical drug compounding services with a ceiling of $3 million and ultimate completion date of September 30, 2030. This is a single-award contract with no set-aside designation. Work is performed at the G.V. Montgomery VA Medical Center in Jackson, Mississippi (1500 E Woodrow Wilson Ave, Jackson, MS 39216). The contract procures contingency...
- The Department of Veterans Affairs' Veterans Integrated Service Network 20 awarded an indefinite-delivery contract to Optum Pharmacy 801, Inc. for pharmacy hazardous compounding services with a ceiling of $20,000.00 and an award date of October 1, 2025. This is a single-award IDIQ with no set-aside designation, with performance extending through September 30, 2030. No specific place of performance is identified in the contract record beyond the contractor's established operations. The...
- Optum Pharmacy 801, Inc., a 503A certified specialty pharmacy subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs for chemotherapy drug compounding services. The contract, valued at $124,987.94 with a period of performance through August 31, 2026, represents a firm fixed-price procurement with no set-aside designation. The awarded task order, issued September...
Veterans Integrated Service Network 15 awarded an indefinite-delivery contract to Optum Infusion Services 308, LLC on September 1, 2026, with a ceiling of $357,644.88 and ultimate completion date of August 31, 2031. This is a single-award, unrestricted contract. The originating solicitation, posted January 13, 2026, requested compounded sterile pharmaceutical preparations and associated supplies for VISN 15 facilities, including hazardous and non-hazardous compounded intravenous products, medications, diluents, fluids, IV tubing, closed-system drug transfer devices, and administration items. All sterile products must be aseptically compounded in compliance with USP 797, USP 800, the Drug Supply Chain Security Act, and applicable federal, state, and local regulations. The contractor is required to provide and annually update the VHA Pharmacy Benefits Management Assessment Guide for Compounded Sterile Preparations. The contract is classified under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC Q517 (Pharmacy Services). Place of performance encompasses VISN 15 facilities across Kansas, Missouri, Nebraska, and Iowa. The base period runs through August 31, 2031, with no separately identified option periods stated in the source. Optum Infusion Services 308, LLC is a subsidiary of UnitedHealth Group Incorporated and delivers FDA 503A-compliant pharmaceutical compounding and hazardous chemotherapy preparation services to the Department of Veterans Affairs. The company operates from multiple locations including Chandler, Arizona; Houston, Texas; and Jackson, Mississippi, with compounding operations serving VA facilities across five Veterans Integrated Service Networks. All work requires next-day delivery capability and adherence to USP 797, 795, and 800 standards for aseptic compounding of hazardous and non-hazardous pharmaceutical agents.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 8/17/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Pharmacy Compounded Sterile Preparation (CSP) VISN 15 | 36C25526R0023 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Solicitation 2/2 | 3/6/26, 2:54 PM | |
Q517--Pharmacy Compounded Sterile Preparation (CSP) Contingency | VISN 15 | Mission Critical | | 36C25526R0023 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Pre-Solicitation 1/2 | 1/13/26, 11:03 AM |